Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis

• 主要な著者: Qian Xiang (著者), Mengxi Wang (著者), Yuhan Ding (著者), Manlu Fan (著者), Huaqin Tong (著者), Jiandong Chen (著者), Peng Yu (著者), Le Shen (著者), Xiaohu Chen (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Heart failure with reduced ejection fraction (HFrEF) is a complex, chronic disease and is among the top causes of morbidity and mortality. Angiotensin receptor-neprilysin inhibitor drugs represented by sacubitril/valsartan are the key drugs for the treatment of HFrEF in western medicine,...